Cytokine patterns in patients who undergo hemofiltration for treatment of multiple organ failure

World Journal of Surgery

Volumn 22, Issue 5, 1998, Pages 443-448

  Koperna, Thomas ^a   Vogl, Sonja E ^a   Pöschl, Gerald P ^a   Hamilton, Gerhard ^a   Roder G ^a   Germann, Peter ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HEMOFILTRATION; HUMAN; INTENSIVE CARE; MALE; MULTIPLE ORGAN FAILURE; OXYGENATION;

ADULT; CYTOKINES; FEMALE; HEMODYNAMIC PROCESSES; HEMOFILTRATION; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031916530     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900413     Document Type: Article

References (32)

1. Barzilay, E., Kessler, D., Berlot, G., Gullo, A., Geber, D., Zeev, LB.: Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients. Crit. Care Med. 77:634, 1989
2. Walz, A., Peveri, P., Aschauer, H., Baggiolini, M.: Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem. Biophys. Res. Commun. 149:755, 1987
3. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20:864, 1992
4. Coraim, F.J., Coraim, H.P., Ebermann, R., Stellwag, F.M.: Acute respiratory failure after cardiac surgery: clinical experience with the application of continuous arteriovenous hemofiltration. Crit. Care Med. 72:714, 1989
5. Grootendorst, A.F., Van Bommel, E.F., Van der Hoven, B.: High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med. 18:235, 1992
6. Roumen, R.M.H., Hendriks, T., Van der Ven-Jongekrijg, J., Nieuwenhuijzen, G.A.P., Sauerwein, R.W., van der Meer, J.W.M., Goris, R.J.A.: Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann. Surg. 218:769, 1993
7. Dinarello, C.A.: Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Kidney Int. 42: S68, 1992
8. Ertel, W., Morrison, M.H., Wang, P.: The complex pattern of cytokines in sepsis. Ann. Surg. 274:141, 1991
9. Goris, R.J.A., te Boekhorst, T.P.A., Nuytinck, K.S., Gimbrere, J.S.F.: Multiple-organ failure: generalized autodestructive inflammation? Arch. Surg. 720:1109, 1985
10. Koperna, T., Schulz, F.: Prognosis and treatment of peritonitis: do we need new scoring systems? Arch. Surg. 737:180, 1996
11. Hirasawa, H., Sugai, T., Ohtake, Y., Shigetoshi, O., Matsuda, K., Kitamura, N.: Continuous hemofiltration and hemodiafiltration in the management of multiple organ failure. Contrib. Nephrol. 93:42, 1991
12. Hirasawa, H., Sugai, T., Ohtake, Y., Shigetoshi, O., Matsuda, K., Kitamura, N.: Blood purification for prevention and treatment of multiple organ failure. World J. Surg. 20:482, 1996
13. Guinard, N., Beloucif, S., Gatecel, C., Mateo, J., Payen, D.: Interest of a therapeutic optimization strategy in severe ARDS. Chest 777:1000, 1997
14. Casey, L.C., Balk, R.A., Bone, R.C.: Plasma cytokine and endotoxine levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 779:771, 1993
15. Meduri, G.U., Headley, S., Kohler, G., Stentz, F., Tolley, E., Um-berger, R., Leeper, K.: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1 and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 707:1062, 1995
16. Bone, R.C.: The pathogenesis of sepsis. Ann. Intern. Med. 775:457, 1991
17. Hesse, D.G., Tracey, K.J., Fong, Y., Manogue, K.R., Palladino, M.A., Shires, T., Lowry, S.F.: Cytokine appearence in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 766:147, 1988
18. Schetz, M., Gasthuisberg, U.Z.: Removal of cytokines in septic patients using continuous veno-venous hemodiafiltration [letter]. Crit. Care Med. 22:715, 1994
19. Krafft, P., Felfernig, M., Papousek, A., Weinstabl, C., Steltzer, H., Hammerle, A.F.: Removal of cytokines in septic patients using continuous veno-venous hemodiafiltration [letter]. Crit. Care Med. 22:716, 1994
20. Byrick, R.J., Goldstein, M.B., Wong, P.Y.: Increased plasma tumor necrosis factor concentration in severe rhabdomyolysis is not reduced by continuous arteriovenous hemodialysis. Crit. Care Med. 20:1483, 1992
21. Schetz, M., Ferdinande, P., van den Berghe, G.: Removal of proinflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive Care Med. 27:169, 1995
22. Bellomo, R., Tipping, P., Boyce, N.: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit. Care Med. 27:522, 1993
23. Hoffmann, J.N., Hartl, W.H., Deppisch, R., Faist, E., Jochum, M., Inthorn, D.: Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int. 48:1563, 1995
24. Donnely, T.J., Meade, P., Jagels, M., Cryer, G., Law, M.M., Hugh, T.E., Shoemaker, W.C., Abraham, E.: Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit. Care Med. 22:768, 1994
25. Shoemaker, W.C., Appel, P.L., Bishop, M.H.: Temporal patterns of blood volume, hemodynamics, and oxygen transport in pathogenesis and therapy of postoperative adult respiratory distress syndrome. New Horiz. 7:522, 1993
26. Meduri, G.U., Kohler, G., Headley, S., Tolley, E., Stentz, F., Postlethwaite, A.: Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome. Chest 705:1303, 1995
27. Journois, D., Pouard, P., Greeley, W.J., Mauriat, P., Vouhe, P., Safran, D.: Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery: effects on hemostasis, cytokines, and complement components. Anesthesiology 81:1181, 1994
28. Rimondini, A., Cipolla, C.M., Delia Bella, P.: Hemofiltration as a short term treatment for refractory congestive heart failure. Am. J. Med. 83:43, 1987
29. Lauer, A., Saccaggi, A., Ronco, C., Belledonne, M., Glabman, S., Bosch, J.P.: Continuous arteriovenous hemofiltration in the critically ill patient: clinical use and operational characteristics. Ann. Intern Med. 99:455, 1983
30. Parrillo, J.E., Burch, C., Shelhammer, J.H., Parker, M.M., Natanson, C., Schuette, W.: A circulating myocardial depressant substance in humans with septic shock. J. Clin. Invest. 76:1539, 1985
31. Parker, M.M., McCarthy, K.E., Ognibene, F.P., Parillo, J.E.: Right ventricular dysfunction and dilatation, similar to left ventricular changes characterize the cardiac depression of septic shock in humans. Chest 97:126, 1990
32. Reilly, J.M., Cunnion, R.E., Burch-Whitman, C., Parker, M.M., Shelhammer, J.H., Parillo, J.E.: A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock. Chest 95:1072, 1989